Pulsed Electromagnetic Fields for Postoperative Pain: a Linical Trial in Humans
Study Details
Study Description
Brief Summary
This randomized clinical trial was designed to assess the clinical efficacy of Pulsed electromagnetic field PEMF delivered with a wearable device in terms of postoperative pain and quality of healing after mandibular third molar extraction.
The sample included 120 patients undergoing unilateral mandibular third molar extraction. The devices were positioned over the area corresponding to the extraction site and wearers were asked to keep them in place for 7 days. All patients were asked to record pain (on a visual analog scale [VAS]), hours of wearing the device (groups T and P), and any use of analgesics. At 7 days, healing complications (dehiscence, tumefaction, pus, local lymphadenopathy, pain on palpation, postoperative bleeding, alveolitis) were recorded blindly.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Introduction: Pulsed electromagnetic field (PEMF) therapy is a noninvasive method for delivering pulsed radiofrequency energy to tissues to treat postoperative pain and edema. This randomized clinical trial was designed to assess the clinical efficacy of PEMF delivered with a wearable device in terms of postoperative pain and quality of healing after mandibular third molar extraction.
Materials and methods: The sample included 120 patients undergoing unilateral mandibular third molar extraction. At the end of the surgical procedure, patients were randomly assigned to a test (T) or placebo (P) group and fitted with enabled or disabled PEMF devices, respectively, or to a control (C) group not fitted with a PEMF device. The devices were positioned over the area corresponding to the extraction site and wearers were asked to keep them in place for 7 days. All patients were asked to record pain (on a visual analog scale [VAS]), hours of wearing the device (groups T and P), and any use of analgesics. At 7 days, healing complications (dehiscence, tumefaction, pus, local lymphadenopathy, pain on palpation, postoperative bleeding, alveolitis) were recorded blindly.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
No Intervention: Control Group (no device) No devices were delivered after third molar tooth extraction |
|
Placebo Comparator: Placebo group (Inactivated device) Inactivated devices were delivered after third molar tooth extraction |
Device: RecoveryRx™
Appliance of the device after surgery
Other Names:
|
Experimental: Test (activated device) Activated devices were delivered after third molar tooth extraction |
Device: RecoveryRx™
Appliance of the device after surgery
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Visual Analog scale [up to day 7 post intervention]
Secondary Outcome Measures
- Quality of healing [day 7 post intervention]
The quality of healing will be measured by scoring the presence of the following: dehiscence, tumefaction, pus, local lymphadenopathy, pain on palpation, postoperative bleeding, alveoli tis will be recorded blindly for each patients. Frequency of complications (per patients) at 7 days. Numerical values and p-values of comparisons will be recorded.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
patients who needs third molar extraction,
-
good oral hygiene,
-
no contraindications to treatment.
Exclusion Criteria:
-
age under 14 years;
-
poor oral hygiene (plaque index less then 20%);
-
contraindications for surgery (or anesthesia);
-
infectious or systemic diseases;
-
immunosuppressant therapy;
-
pregnancy or breastfeeding;
-
mental disorders.
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- University of Padova, School of Dental Medicine
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2976P